Babafemi Taiwo
Babafemi Taiwo, Vice President & Head, Early Development at ViiV Healthcare.
ArticleAdvancing next generation integrase inhibitors for HIV
This Q&A discusses how long‑acting integrase inhibitors are shaping the future of HIV drug development, including key lessons learned and recent clinical findings from ViiV Healthcare’s pipeline.